JIANGXI KVVIT PHARM
GenericsJIANGXI KVVIT PHARM is a generic drug manufacturer focused on Oncology, Dermatology.
JIANGXI KVVIT PHARM's Key Drugs
JIANGXI KVVIT PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
JIANGXI KVVIT PHARM's Recent FDA Approvals
New NDA/BLA approvals for JIANGXI KVVIT PHARM over the last two years — novel drugs only, excluding generics and label supplements.
JIANGXI KVVIT PHARM's Therapeutic Areas
JIANGXI KVVIT PHARM's approved drugs and pipeline span 2 therapeutic areas, led by Oncology and Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
JIANGXI KVVIT PHARM's Top Competitors
JIANGXI KVVIT PHARM's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
JIANGXI KVVIT PHARM Pipeline Snapshot
JIANGXI KVVIT PHARM has 1 active clinical program from ClinicalTrials.gov — 0 Phase 3, 1 Phase 2 and 0 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2024-06-28
- Latest
- 2024-06-28
- Applications
- 1